IP Library Granted Patent US 11,040,948
Granted Patent B2
US 11,040,948 · App. 16/651,830 · Granted Jun 22, 2021

Crystal forms of immunomodulators

Inventor: Shu Yu (Jiangsu, CN)
Assignee: Curis, Inc.
C07D271/06C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,040,948
App. No.
16/651,830
Granted
Jun 22, 2021
Kind
B2
Abstract

The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, including an anhydrous crystalline form, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.

Claims (36)

1. An anhydrous crystalline compound having the structure of formula (I),

2. The anhydrous crystalline compound of claim 1 , having 2θ values 18.8±0.2, 20.5±0.2, 26.4±0.2, 27.5±0.2, and 32.0±0.2.

3. The anhydrous crystalline compound of claim 2 , having 2θ values 18.8±0.2, 20.5±0.2, 26.1±0.2, 26.4±0.2, 27.5±0.2, 30.6±0.2, and 32.0±0.2.

4. The anhydrous crystalline compound of claim 3 , having 2θ values 15.8±0.2, 16.5±0.2, 18.8±0.2, 20.5±0.2, 25.5±0.2, 26.1±0.2, 26.4±0.2, 27.5±0.2, 30.6±0.2, and 32.0±0.2.

5. The anhydrous crystalline compound of claim 4 , having 2θ values 15.8±0.2, 16.5±0.2, 18.8±0.2, 20.5±0.2, 21.8±0.2, 22.3±0.2, 24.2±0.2, 25.5±0.2, 26.1±0.2, 26.4±0.2, 27.5±0.2, 30.4±0.2, 30.6±0.2, and 32.0±0.2.

6. The anhydrous crystalline compound of claim 5 , having an XRD pattern substantially as shown in FIG. 3 .

7. A pharmaceutical composition comprising the anhydrous crystalline compound of claim 1 and one or more pharmaceutically acceptable excipients.

8. A method for preparing an anhydrous crystalline compound having the structure of formula (I):

comprising the steps of:

a) providing a mixture comprising a compound of formula (I) and a solvent; and

b) crystallizing the compound of formula (I) from the mixture comprising the compound of formula (I).

9. The method of claim 8 , wherein the method comprises the steps of:

a) providing a mixture comprising a compound of formula (I) and a solvent;

b) adding an anti-solvent to the mixture; and

c) crystallizing the compound of formula (I) from the mixture comprising the compound of formula (I).

10. The method of claim 9 , wherein the method comprises the steps of:

a) providing a mixture comprising a compound of formula (I) and a solvent;

b) adding an anti-solvent to the mixture;

c) adding seed crystals to the mixture;

d) adding additional anti-solvent to the mixture; and

e) crystallizing the compound of formula (I) from the mixture comprising the compound of formula (I).

11. The method of claim 8 , wherein the solvent is selected from acetonitrile, anisole, dichloromethane, ethanol, isopropyl acetate, methyl tert-butyl ether (MTBE), n-heptane, tetrahydrofuran, water, and mixtures thereof.

12. The method of claim 11 , wherein the mixture further comprises a solvent selected from ethanol, isopropanol, methanol, tetrahydrofuran, 1,4-dioxane, acetonitrile, and acetone.

13. The method of claim 8 , wherein the mixture comprising the compound of formula (I) and the solvent is a reaction mixture.

14. The method of claim 10 , wherein, the anti-solvent is selected from tetrahydrofuran, methanol, isopropanol, diethyl ether, ethanol, 1,4-dioxane, acetonitrile, and acetone.

15. The method of claim 8 , wherein the mixture further comprises seed crystals.

16. The method of claim 15 , wherein the seed crystals are added at a weight percentage of the total mixture selected from about 1 wt %, about 2 wt %, about 3 wt %, about 4 wt %, about 5 wt %, about 6 wt %, about 7 wt %, about 8 wt %, about 9 wt %, and about 10 wt %.

17. The method of claim 16 , wherein the seed crystals are formula (I) Form A seed crystals.

18. The method of claim 8 , wherein the mixture comprising the compound of formula (I) is a solution.

19. The method of claim 18 , wherein the solution comprises a crude solid material comprising the compound of formula (I) dissolved in a solvent.

20. The method of claim 8 , wherein the mixture comprising the compound of formula (I) is a solution, and the step of crystallizing the compound of formula (I) from the mixture comprises bringing the solution to supersaturation to cause the compound of formula (I) to precipitate out of solution.

21. The method of claim 20 , wherein the step of bringing the solution to supersaturation comprises slowly adding an anti-solvent, allowing the solution to cool, reducing the volume of the solution, or any combination thereof.

22. The method of claim 8 , wherein the mixture comprising the compound of formula (I) is a slurry.

23. The method of claim 22 , wherein the slurry comprises crude solid material comprising the compound of formula (I).

24. The method of claim 19 , wherein the crude solid material comprises about 70% to about 90% compound of formula (I).

25. The method of claim 8 , wherein the purity of the crystalline form of the compound of formula (I) is selected from about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, and about 99%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2020
From: YU, SHU
To: CURIS, INC.
Reel/Frame 052429/0202 →
Priority Claims (1)
WO PCT/CN2017/104485 · Sep 29, 2017 · international
Continuity (1)
Related Publication 20200247766A1 · Aug 6, 2020
Cited By (4)
US 12,187,689 US 12,226,402 US 12,252,475 US 12,643,870